3rd Non-Viral RNA Delivery Systems Summit Wyndham Boston Beacon Hill, Boston

There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.

Hence, this October the 3rd Non-Viral RNA Delivery Systems Summit is being brought back to Boston as the first and only industry-led event focussed on non-viral delivery systems, such as LNPs, exosomes, polymers, peptides and more, for RNA payloads to advance potent and efficacious therapeutics towards the patients in need.

Join 80+ RNA delivery experts from the likes of AstraZeneca, Sanofi, Novo Nordisk, Tessera Therapeutics, Replicate Biosciences, Sanegene Bio and more to discuss novel and innovative delivery strategies for overcoming the challenges of endosomal escape and delivering beyond the liver to advance RNA therapeutics into the clinic and towards approval.